Future Microbiology · 2019 · 35 citations · 27 references
PharmacyMedicinal ChemistryPharmacologyAntimicrobial ResistanceChemotherapyDrug DiscoveryAntibacterial AgentsAntibacterial PharmacologyAntibacterial PharmacotherapyAntibacterial TherapyEfflux-mediated ResistanceTuberculosis PharmacotherapyBacterial Efflux PumpsBactericidal AgentsDrug Efflux PumpsMultidrug-resistant OrganismsMultidrug-resistant PathogensMycobacterium Tuberculosis InfectionTuberculosis Drug DevelopmentTuberculosis Drug Resistance
Aim: To evaluate the potential of three benzohydrazones (1–3), four acylhydrazones derived from isoniazid (INH-acylhydrazones) (4–7) and one hydrazone (8) as antituberculosis agents. Materials & methods: Inhibitory and bactericidal activities were determined for the reference Mycobacterium tuberculosis (Mtb) strain and clinical isolates. Cytotoxicity, drug combinations and ethidium bromide accumulation assays were also performed. Results: The tested compounds (1–8) presented excellent antituberculosis activity with surprisingly inhibitory (0.12–250 μg/ml) and bactericidal values, even against multidrug-resistant Mtb clinical isolates. Compounds showed high selectivity index, with values reaching 1833.33, and a limited spectrum of activity. Some of the compounds (2 & 8) are also great inhibitors of bacillus efflux pumps. Conclusion: Benzohydrazones and INH-acylhydrazones may be considered scaffolds for the development of new anti-Mtb drugs.
27
Juan-Carlos Palomino, Anandi Martin, Mirtha Camacho et al. · Antimicrobial Agents and Chemotherapy · 2002 · 1.2K citations · Full text